<--- Back to Details
First PageDocument Content
Health / Pharmacology / Fluocinonide / Organofluorides / Autoimmune diseases / Corticosteroids / Topical steroid / Atopic dermatitis / Psoriasis / Medicine / Type 1 hypersensitivity / Glucocorticoids
Date: 2013-03-21 13:04:42
Health
Pharmacology
Fluocinonide
Organofluorides
Autoimmune diseases
Corticosteroids
Topical steroid
Atopic dermatitis
Psoriasis
Medicine
Type 1 hypersensitivity
Glucocorticoids

Vanos PI CPL[removed]indd

Add to Reading List

Source URL: pi.medicis.us

Download Document from Source Website

File Size: 597,08 KB

Share Document on Facebook

Similar Documents

25SA16A ________________________________________________________________________________________________________ Glyphosate pathways to modern diseases VI: Prions, amyloidoses and autoimmune neurological diseases Anthony

DocID: 1voae - View Document

National Institute of Allergy and Infectious Diseases Awards MERS/SARS Coronavirus Drug Research Grant to Autoimmune Technologies FOR IMMEDIATE RELEASE New Orleans, June 24, Autoimmune Technologies LLC, a New Orle

DocID: 1uTGp - View Document

The Microbiome, which feeds a myriad of Autoimmune Diseases PRESENTED BY PROFESSOR TREVOR G MARSHALL Autoimmunity Research Foundation, CA, USA Murdoch University, Western Australia Autoimmunity Congress Granada, Spain, M

DocID: 1upLN - View Document

BioMed 258 Final Paper Eve Nakamura Autoimmune Cytopenias Autoimmune diseases are caused by a combination of genetic, epigenetic, and environmental factors and

DocID: 1u7zf - View Document

Medicine / Biology / Clinical medicine / Biotechnology / Immunology / ActoBiotics / Autoimmune diseases / Bacteriology / Biopharmaceutical / Immunogenicity / Mucositis / Human microbiota

Overview ActoBiotics® Platform: A Novel Class of Oral Biotherapeutics

DocID: 1rtnN - View Document